These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 21263247

  • 1. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
    Carney EM, Banerjee P, Ellis CL, Albadine R, Sharma R, Chaux AM, Burger PC, Netto GJ.
    Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247
    [Abstract] [Full Text] [Related]

  • 2. PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis.
    Zhao M, Williamson SR, Yu J, Xia W, Li C, Zheng J, Zhu Y, Sun K, Wang Z, Cheng L.
    Hum Pathol; 2013 Oct; 44(10):2247-55. PubMed ID: 23849894
    [Abstract] [Full Text] [Related]

  • 3. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma.
    Kuroda N, Agatsuma Y, Tamura M, Martinek P, Hes O, Michal M.
    Int J Clin Exp Pathol; 2015 Oct; 8(2):2131-8. PubMed ID: 25973115
    [Abstract] [Full Text] [Related]

  • 4. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
    Ozcan A, de la Roza G, Ro JY, Shen SS, Truong LD.
    Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].
    Zhang W, Yu WJ, Xia Y, Liu Y, Liu XL, Zhuang J, Li YJ.
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861
    [Abstract] [Full Text] [Related]

  • 8. PAX8 Expression Variability in Cerebellar Hemangioblastoma: Case Series and Review of the Literature.
    Eichberg DG, Buttrick S, White K, Gultekin SH, Komotar RJ.
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):477-481. PubMed ID: 29629948
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
    Weinbreck N, Marie B, Bressenot A, Montagne K, Joud A, Baumann C, Klein O, Vignaud JM.
    Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143
    [Abstract] [Full Text] [Related]

  • 10. PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract.
    Albadine R, Schultz L, Illei P, Ertoy D, Hicks J, Sharma R, Epstein JI, Netto GJ.
    Am J Surg Pathol; 2010 Jul; 34(7):965-9. PubMed ID: 20463571
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
    Zhou J, Li NY, Zhou XJ, Zhou HB, Wu B, Jiang SJ, Ma HH, Zhang RS.
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
    [Abstract] [Full Text] [Related]

  • 14. Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas.
    Brown DF, Gazdar AF, White CL, Yashima K, Shay JW, Rushing EJ.
    J Neuropathol Exp Neurol; 1997 Dec; 56(12):1349-55. PubMed ID: 9413283
    [Abstract] [Full Text] [Related]

  • 15. Metastases to hemangioblastomas in von Hippel-Lindau disease.
    Jarrell ST, Vortmeyer AO, Linehan WM, Oldfield EH, Lonser RR.
    J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
    [Abstract] [Full Text] [Related]

  • 16. PAX2 and PAX8: useful markers for metastatic effusions.
    Waters L, Crumley S, Truong L, Mody D, Coffey D.
    Acta Cytol; 2014 Aug; 58(1):60-6. PubMed ID: 24334997
    [Abstract] [Full Text] [Related]

  • 17. PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.
    Tong GX, Memeo L, Colarossi C, Hamele-Bena D, Magi-Galluzzi C, Zhou M, Lagana SM, Harik L, Oliver-Krasinski JM, Mansukhani M, Falcone L, Hibshoosh H, O'Toole K.
    Am J Surg Pathol; 2011 Oct; 35(10):1473-83. PubMed ID: 21934480
    [Abstract] [Full Text] [Related]

  • 18. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma.
    Rivera AL, Takei H, Zhai J, Shen SS, Ro JY, Powell SZ.
    Neuropathology; 2010 Dec; 30(6):580-5. PubMed ID: 20374497
    [Abstract] [Full Text] [Related]

  • 19. Sporadic hemangioblastoma of the kidney with PAX2 and focal CD10 expression: report of a case.
    Jiang JG, Rao Q, Xia QY, Tu P, Lu ZF, Shen Q, Zhang RS, Yu B, Zhou XJ, Shi SS, Shi QL.
    Int J Clin Exp Pathol; 2013 Dec; 6(9):1953-6. PubMed ID: 24040464
    [Abstract] [Full Text] [Related]

  • 20. Malignant tumors with clear cell morphology: a comparative immunohistochemical study with renal cell carcinoma antibody, Pax8, steroidogenic factor 1, and brachyury.
    Clayton EF, Ziober A, Yao Y, Bing Z.
    Ann Diagn Pathol; 2013 Apr; 17(2):192-7. PubMed ID: 23218904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.